News

Some people buy a car but never put the title in their name (usually to avoid sales taxes). Title jumping is illegal, and if you purchase a vehicle under those conditions, you may have difficulty ...
Stock trading is a fascinating activity, but it shouldn't be entered into lightly. Learn how it works and what pitfalls to avoid as a beginner.
Shares to buy or sell: Chandan Taparia has recommended two stocks to buy today – Bharat Electronics (BEL) and Dr Reddy’s Laboratories shares – and has suggested selling IEX stock futures.
Although the stock initially soared nearly 40% above its IPO price of $27, opening at $43, prices have since declined, with the stock currently trading just below $35.
The case to buy or hold Dollar Tree stock Dollar Tree stands out with a simple, value-driven business model in a crowded retail landscape where consumers have countless options. The company offers ...
The NFL defines parity.Why we're selling: This is still a team that hasn’t won a home game in regulation since 2023. They do have plenty of experience, but those vets (Dan Moore Jr., Kevin ...
Image source: Getty Images. The case to buy or hold Dollar Tree stock Dollar Tree stands out with a simple, value-driven business model in a crowded retail landscape where consumers have countless ...
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — Sakar Healthcare, Yuken India, DEE Development Engineers, NDR Auto Components, and Pearl Global Industries.
By Jacob Lev and Matt Egan, CNN (CNN) — The Buss family has agreed to sell majority ownership of the Los Angeles Lakers, one of the most storied franchises in all of sports, to Los Angeles ...
Over the past five years, there have been 20 earnings data points recorded, consisting of 10 positive and 10 negative one-day (1D) returns. In total, positive 1D returns occurred approximately 50% ...
Also, the tragic crash in India won’t have helped passenger confidence. Stepping back then, I can see why investors have been pressing the sell button. IAG stock is down 8% in a week.
2. Merck Merck owns the world's best-selling drug, Keytruda, which is approved to treat many different cancers. However, the medicine will run into a patent cliff in the U.S. by 2028. In the ...